Global exosome research market was valued at US$ 174.94 million in 2022 and is anticipated to record a revenue of US$ 1,158.04 Million by 2031 at a CAGR of 24.4% over the forecast period of 2023 to 2031.
India specialty drug distribution market generated a revenue of US$ 2,045.35 million in 2022 and is estimated to reach a valuation of US$ 5,997.7 million by 2031 at a CAGR of 12.93% during the forecast period 2023–2031.
ASEAN nutritional supplements market generated revenue of US$ 7,366.8 million in 2022 and it is estimated to reach valuation of US$ 14,847.3 million by 2031 at a CAGR of 8.4% during the forecast period, 2023–2031.
ASEAN & US corporate wellness market is anticipated to reach valuation of US$ 30.82 Bn in 2030 from US$ 18.29 Bn in 2021. The market is expected to register healthy growth at a CAGR of 5.88 % during the forecast period 2022–2030.
Japan pet cancer therapeutics market was valued at US$ 14.0 Million in 2021 and is projected to reach a valuation of US$ 26.1 Million by 2031 at a CAGR of 7.3% during the forecast period 2023-2031.
Global dermatology drugs market was valued at US$ 18.42 billion in 2022 and is estimated to reach a valuation of US$ 45.35 billion and 79.24 metric ton, in terms of volume by 2031. The market is anticipated to grow at a CAGR of 11.0% during the forecast period 2023-2031
Asia Pacific Dermal Fillers Treatment Market is estimated to witness a rise in revenue from US$ 810.3 Million in 2021 to US$ 1,650.3 Million by 2030. The market is registering a CAGR of 8.9% during the forecast period 2022-2030
Global Osimertinib Drugs Market is estimated to witness a rise in revenue from US$ 4,828.6 Mn in 2021 to US$ 11,829.8 Mn by 2027. The market is registering a CAGR of 16.1% during the forecast period 2022-2027
The global over-the-counter (OTC) drugs market is expected to experience significant growth, with revenue projected to rise from US$ 1,29,963.03 Mn in 2022 to US$ 2,38,453.92 Mn by 2031, registering a CAGR of 7.0% during the forecast period.